Joint Venture: AMBS --> $600,000 --> MTSL AMBS -
Post# of 30028
AMBS --> $600,000 --> MTSL
AMBS --> Minority interest in Cutanogen --> MTSL
AMBS <-- 1,098,000 MTSL shares (25%) <-- MTSL
Option:
AMBS --> Total of 90% of Cutanogen OS --> MTSL
AMBS <-- 2,109,342 MTSL shares (50%) <-- MTSL
Merger
MTSL and/or Cutanogen raised a minimum $5,000,000 at the time of closing of the Merger.
MTSL shareholders (pre-JV) receive a minimum of 15% (468,102) of the then outstanding common shares following the merger.
Tender Offer
The Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a tender offer if as a result of the acquisition the purchaser would become a 25% or greater shareholder of the company.
Outstanding Shares: 3,120,684
Likely Additional Share: 1,098,000
Total Shares: 4,218,684